tiprankstipranks
Zymeworks Inc (ZYME)
NASDAQ:ZYME

Zymeworks (ZYME) Stock Investors

463 Followers
Based on 743,304 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold ZYME
On average, investors allocate 2.75% of their portfolios to ZYME
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Negative
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 743,304 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding ZYME

4.4%
Last 7
Days
2.6%
Last 30
Days
Percentages indicate the change in the number of portfolios holding ZYME, out of 743,304 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

ZYME Investor Activity

Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Increased
0.38%
$8.33
Based on the activity of 14,057 investors who made their portfolios public
The table shows changes in ZYME in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

ZYME Investors Also Bought

Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Merck & Company
3.93%
+0.37%
+2.73%
328.81B
Healthcare
Trade Desk
4.69%
-1.21%
+0.40%
48.04B
Technology
DraftKings
5.74%
-0.70%
-1.19%
32.57B
Consumer Cyclical
Baidu
5.02%
+1.56%
+10.88%
32.01B
Communication Services
Bristol-Myers Squibb
3.22%
+0.25%
+1.20%
84.14B
Healthcare
Block
4.16%
-0.54%
-1.39%
39.11B
Technology
Applied Materials
4.73%
+0.66%
+4.00%
192.53B
Technology
ChargePoint Holdings
4.00%
-0.82%
-2.26%
642.21M
Consumer Cyclical
PDD Holdings
4.91%
+0.13%
+4.77%
175.29B
Consumer Cyclical
Enphase Energy
4.91%
-0.62%
-1.93%
14.32B
Technology
Based on the activity of 743,304 active portfolios
Open your Smart Portfolio

ZYME Investor Analysis

ZYME investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
6.0%
of ZYME holders
are under 35
Average Segment Performance
Average P/E Ratio21.46
Beta7.39
Dividend Yield6.06%
ZYME investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
53.6%
of ZYME holders
are between 35–55
Average Segment Performance
Average P/E Ratio20.66
Beta13.51
Dividend Yield6.08%
ZYME investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
40.5%
of ZYME holders
are over 55
Average Segment Performance
Average P/E Ratio20.71
Beta4.77
Dividend Yield7.20%
Overview of age group and performance of ZYME stock investors
See who invests in ZYME according to age group and performance.

FAQ

How many retail Investors hold ZYME?
<0.1% of TipRanks' retail investors hold ZYME in their portfolios.
    What is ZYME Investor Sentiment?
    ZYME’s Investor Sentiment is Very Negative.
      What percentage of retail investors changed their holding of ZYME in the last 7 days?
      ▼ 4.4% of TipRanks' retail investors changed their holding of ZYME in the last 7 days.
        What percentage of retail investors changed their holding of ZYME in the last 30 days?
        ▼ 2.6% of TipRanks' retail investors changed their holding of ZYME in the last 30 days.
          What is the average age of retail investors who hold ZYME?
          The average age of ZYME Holders is between 35–55.
            What other stocks have ZYME investors also bought?
            ZYME Investors also bought MRK, TTD, DKNG, BIDU, BMY, SQ, AMAT, CHPT, PDD, ENPH.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              ACADACADIA Pharmaceuticals
              AZNAstraZeneca
              BCRXBioCryst
              BSXBoston Scientific
              EWEdwards Lifesciences
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis